Efficacy of dapagliflozin plus saxagliptin vs insulin glargine at 52 weeks in patients with type 2 diabetes inadequately controlled by metformin with or without sulfonylurea

被引：0
|
作者：
Vilsboll, T. [1 ]
Ekholm, E. [2 ]
Johnsson, E. [2 ]
Garcia-Sanchez, R. [3 ]
Dronamraju, N. [3 ]
Jabbour, S. A. [4 ]
Lind, M. [5 ]
机构：
[1] Steno Diabet Ctr, Copenhagen, Denmark
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Gaithersburg, MD USA
[4] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[5] Univ Gothenburg, Gothenburg, Sweden
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
775
引用
收藏
页码：S380 / S380
页数：1
相关论文
共 50 条
  • [1] Dapagliflozin plus Saxagliptin Shows Noninferior A1C Reduction vs. Insulin Glargine in Patients with Type 2 Diabetes Inadequately Controlled by Metformin With or Without Sulfonylurea
    Vilsboll, Tina
    Ekholm, Ella
    Johnsson, Eva K.
    Dronamraju, Nalina
    Jabbour, Serge
    Lind, Marcus
    [J]. DIABETES, 2018, 67
  • [2] Insulin glargine improves health related quality of life in patients with type 2 diabetes inadequately controlled on sulfonylurea plus metformin
    Vinik, AI
    Dailey, G
    Zhang, Q
    [J]. DIABETOLOGIA, 2005, 48 : A312 - A312
  • [3] Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes
    Mathieu, C.
    Herrera Marmolejo, M.
    Gonzalez Gonzalez, J. G.
    Hansen, L.
    Chen, H.
    Johnsson, E.
    Garcia-Sanchez, R.
    Iqbal, N.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (11): : 1134 - 1137
  • [4] Efficacy and safety of saxagliptin plus metformin versus acarbose plus metformin in type 2 diabetes patients inadequately controlled with metformin monotherapy
    Du, J.
    Liang, L.
    Fang, H.
    Xu, F.
    Li, W.
    Shen, L.
    Mu, Y.
    [J]. DIABETOLOGIA, 2016, 59 : S372 - S372
  • [5] Efficacy of Insulin Glargine Plus 1 Injection of Insulin Glulisine in Patients with Type 2 Diabetes Inadequately Controlled by Insulin Glargine
    Charpentier, Guillaume
    [J]. DIABETES, 2014, 63 : A237 - A237
  • [6] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
  • [7] Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial
    Vilsboll, Tina
    Ekholm, Ella
    Johnsson, Eva
    Dronamraju, Nalina
    Jabbour, Serge
    Lind, Marcus
    [J]. DIABETES CARE, 2019, 42 (08) : 1464 - 1472
  • [8] Efficacy of Combination of Insulin Glargine with either Metformin or Sulfonylurea in Patients with Poorly Controlled Type 2 Diabetes
    Chuang, Shih-Ming
    Wang, Chao-Hung
    Liu, Sung-Chen
    Chien, Ming-Nan
    Chen, Wei-Che
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2020, 14 (02) : 138 - 141
  • [9] Vildagliptin efficacy and safety in patients with type 2 diabetes inadequately controlled on dual metformin plus sulfonylurea therapy
    Lukashevich, V.
    Wang, M.
    Del Prato, S.
    Araga, M.
    Kothny, W.
    [J]. DIABETOLOGIA, 2012, 55 : S353 - S353
  • [10] Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial
    Vilsboll, Tina
    Ekholm, Ella
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Dronamraju, Nalina
    Jabbour, Serge A.
    Lind, Marcus
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (06): : 957 - 968
12345